Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Hyperplasia | 11 | 2024 | 530 | 3.000 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 6 | 2024 | 70 | 2.590 |
Why?
|
Prostate | 10 | 2024 | 1793 | 2.280 |
Why?
|
5-alpha Reductase Inhibitors | 4 | 2024 | 117 | 1.040 |
Why?
|
Estrogen Receptor alpha | 3 | 2024 | 580 | 0.820 |
Why?
|
Membrane Proteins | 6 | 2024 | 7850 | 0.810 |
Why?
|
Metformin | 4 | 2017 | 912 | 0.800 |
Why?
|
Androstenes | 1 | 2020 | 182 | 0.630 |
Why?
|
DNA Methylation | 7 | 2020 | 4373 | 0.600 |
Why?
|
Prostatic Diseases | 1 | 2017 | 57 | 0.580 |
Why?
|
Epigenesis, Genetic | 4 | 2020 | 3758 | 0.550 |
Why?
|
Cell Proliferation | 8 | 2024 | 10446 | 0.530 |
Why?
|
Estrogens | 2 | 2020 | 1520 | 0.520 |
Why?
|
Epithelial Cells | 3 | 2024 | 3663 | 0.470 |
Why?
|
Aromatase | 3 | 2020 | 147 | 0.460 |
Why?
|
Estradiol | 2 | 2018 | 1932 | 0.450 |
Why?
|
Androgens | 1 | 2020 | 1291 | 0.400 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2015 | 626 | 0.390 |
Why?
|
Urinary Bladder Diseases | 1 | 2012 | 169 | 0.380 |
Why?
|
Drugs, Chinese Herbal | 2 | 2020 | 151 | 0.380 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 257 | 0.380 |
Why?
|
Prostatectomy | 5 | 2020 | 1956 | 0.380 |
Why?
|
Somatomedins | 1 | 2011 | 178 | 0.360 |
Why?
|
Urinary Bladder, Overactive | 1 | 2012 | 114 | 0.360 |
Why?
|
Growth Hormone | 1 | 2011 | 568 | 0.320 |
Why?
|
Neovascularization, Pathologic | 3 | 2015 | 2640 | 0.320 |
Why?
|
Testosterone | 1 | 2017 | 2470 | 0.280 |
Why?
|
Aloe | 1 | 2005 | 2 | 0.260 |
Why?
|
Promoter Regions, Genetic | 6 | 2020 | 5785 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4357 | 0.250 |
Why?
|
Radiation-Protective Agents | 1 | 2005 | 88 | 0.250 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2019 | 2276 | 0.240 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2049 | 0.240 |
Why?
|
Plants, Medicinal | 1 | 2005 | 166 | 0.240 |
Why?
|
Stromal Cells | 3 | 2020 | 1326 | 0.230 |
Why?
|
Prostatic Neoplasms | 6 | 2022 | 11345 | 0.200 |
Why?
|
Obesity | 2 | 2020 | 12922 | 0.170 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2023 | 517 | 0.170 |
Why?
|
3T3-L1 Cells | 1 | 2020 | 209 | 0.170 |
Why?
|
Transurethral Resection of Prostate | 1 | 2020 | 85 | 0.160 |
Why?
|
Finasteride | 1 | 2020 | 90 | 0.160 |
Why?
|
Polysaccharides | 1 | 2005 | 1016 | 0.160 |
Why?
|
Cell Line, Transformed | 2 | 2017 | 869 | 0.150 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 195 | 0.140 |
Why?
|
Cyclin D | 1 | 2017 | 72 | 0.140 |
Why?
|
Cystectomy | 2 | 2019 | 697 | 0.140 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18137 | 0.140 |
Why?
|
Systems Biology | 1 | 2020 | 482 | 0.140 |
Why?
|
Texas | 1 | 2017 | 401 | 0.140 |
Why?
|
Phosphorylation | 2 | 2017 | 8313 | 0.130 |
Why?
|
Male | 24 | 2024 | 359744 | 0.130 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2015 | 47 | 0.120 |
Why?
|
Receptor, IGF Type 1 | 1 | 2017 | 380 | 0.120 |
Why?
|
Signal Transduction | 9 | 2020 | 23376 | 0.110 |
Why?
|
Mice, Knockout | 2 | 2024 | 14372 | 0.110 |
Why?
|
Cell Cycle | 2 | 2017 | 2934 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2053 | 0.110 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3446 | 0.110 |
Why?
|
Estrogen Replacement Therapy | 1 | 2020 | 1206 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2011 | 256 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2015 | 730 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1173 | 0.110 |
Why?
|
Adipocytes | 1 | 2020 | 1179 | 0.110 |
Why?
|
Citrates | 1 | 2013 | 135 | 0.110 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 608 | 0.100 |
Why?
|
Transfection | 2 | 2017 | 5781 | 0.100 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5889 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 800 | 0.100 |
Why?
|
Mice | 9 | 2024 | 81208 | 0.100 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 724 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1804 | 0.100 |
Why?
|
RNA Interference | 2 | 2017 | 2846 | 0.100 |
Why?
|
Prognosis | 7 | 2022 | 29658 | 0.100 |
Why?
|
Aging | 3 | 2021 | 8651 | 0.100 |
Why?
|
Humans | 31 | 2024 | 760621 | 0.100 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2011 | 21 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1902 | 0.090 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 307 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1881 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.090 |
Why?
|
Cadherins | 1 | 2015 | 898 | 0.090 |
Why?
|
Animals | 11 | 2024 | 167963 | 0.090 |
Why?
|
rho-Associated Kinases | 1 | 2012 | 281 | 0.090 |
Why?
|
Urinary Bladder | 2 | 2018 | 1166 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2011 | 285 | 0.090 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 557 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2011 | 206 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 576 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1337 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2943 | 0.090 |
Why?
|
Neoplasms | 2 | 2015 | 22072 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1928 | 0.080 |
Why?
|
Blood Vessels | 1 | 2015 | 1112 | 0.080 |
Why?
|
Liver | 2 | 2020 | 7509 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3301 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3505 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2165 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12293 | 0.070 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3844 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2012 | 1201 | 0.070 |
Why?
|
Erythropoietin | 1 | 2011 | 720 | 0.070 |
Why?
|
Aged | 14 | 2023 | 169152 | 0.070 |
Why?
|
Up-Regulation | 2 | 2015 | 4122 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8515 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1139 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11481 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3959 | 0.070 |
Why?
|
Organ Size | 2 | 2021 | 2254 | 0.060 |
Why?
|
Fibrosarcoma | 1 | 2007 | 308 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2007 | 590 | 0.060 |
Why?
|
Cyclin B1 | 1 | 2005 | 58 | 0.060 |
Why?
|
Cyclin B | 1 | 2005 | 104 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58995 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4925 | 0.060 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2007 | 617 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1755 | 0.060 |
Why?
|
Antigens, CD | 1 | 2015 | 4000 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9280 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2418 | 0.060 |
Why?
|
X-Rays | 1 | 2005 | 307 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2803 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2017 | 18957 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12914 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2873 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6544 | 0.050 |
Why?
|
Middle Aged | 12 | 2021 | 220352 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2011 | 2050 | 0.050 |
Why?
|
Urethra | 1 | 2023 | 406 | 0.050 |
Why?
|
Survival Rate | 3 | 2022 | 12808 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2299 | 0.050 |
Why?
|
Disease Progression | 4 | 2020 | 13502 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2020 | 65017 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2015 | 16939 | 0.040 |
Why?
|
Marital Status | 1 | 2022 | 433 | 0.040 |
Why?
|
Medicine, Chinese Traditional | 1 | 2020 | 73 | 0.040 |
Why?
|
Immunotherapy | 1 | 2015 | 4642 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3618 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8547 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3607 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4319 | 0.040 |
Why?
|
Isoenzymes | 2 | 2014 | 1690 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2005 | 1183 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2013 | 3218 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 24123 | 0.030 |
Why?
|
SEER Program | 1 | 2022 | 1530 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2014 | 13262 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1613 | 0.030 |
Why?
|
Urothelium | 1 | 2018 | 277 | 0.030 |
Why?
|
Adipogenesis | 1 | 2018 | 358 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1347 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2005 | 2919 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12159 | 0.030 |
Why?
|
Mice, SCID | 2 | 2011 | 2627 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 251 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 936 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10547 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 511 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10182 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39261 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1547 | 0.030 |
Why?
|
Carboxylic Acids | 1 | 2013 | 90 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13630 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1082 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 352 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 2013 | 459 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 600 | 0.020 |
Why?
|
Extracellular Fluid | 1 | 2013 | 165 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2011 | 107 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11071 | 0.020 |
Why?
|
Cell Line | 1 | 2005 | 15620 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5253 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9276 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1858 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 80372 | 0.020 |
Why?
|
Female | 7 | 2023 | 391270 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6771 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3584 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3529 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2222 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22023 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1484 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2007 | 256 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1221 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40165 | 0.020 |
Why?
|
Pericytes | 1 | 2007 | 293 | 0.020 |
Why?
|
Capillaries | 1 | 2007 | 744 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8056 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4902 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5794 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12103 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12531 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4573 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2913 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3765 | 0.010 |
Why?
|
Cognition | 1 | 2020 | 6957 | 0.010 |
Why?
|
Anemia | 1 | 2011 | 1511 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6786 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2007 | 1485 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5791 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9501 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18416 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7588 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20509 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9467 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54303 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5206 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4433 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36290 | 0.010 |
Why?
|
United States | 1 | 2020 | 72461 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23711 | 0.010 |
Why?
|
Adult | 1 | 2020 | 219994 | 0.000 |
Why?
|